Hwaseong-Si, South Korea

Jung-Gun Joung


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):

Title: Jung-Gun Joung: Innovator in Pharmaceutical Composition

Introduction

Jung-Gun Joung is a notable inventor based in Hwaseong-Si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of liver diseases. His innovative work focuses on developing solutions for non-alcoholic steatohepatitis (NASH), a condition that affects many individuals worldwide.

Latest Patents

Joung holds a patent for a pharmaceutical composition aimed at preventing or treating non-alcoholic steatohepatitis. This invention relates to the medical use of a compound, identified as Chemical Formula 1, which is designed to treat, alleviate, or prevent NASH and hepatic fibrosis. This patent highlights his commitment to addressing critical health issues through innovative solutions.

Career Highlights

Joung is associated with J2H Biotech Inc., where he continues to advance his research and development efforts. His work at the company reflects his dedication to improving medical treatments and enhancing patient outcomes. With one patent to his name, he is recognized for his contributions to the pharmaceutical industry.

Collaborations

Joung collaborates with esteemed colleagues, including Jae-Sun Kim and Hyung-Chul Ryu. Their combined expertise fosters a productive environment for innovation and research within the company.

Conclusion

Jung-Gun Joung is a prominent figure in the pharmaceutical field, with a focus on developing treatments for liver diseases. His patent for a pharmaceutical composition demonstrates his innovative approach to addressing significant health challenges. Through his work at J2H Biotech Inc. and collaborations with fellow researchers, he continues to make strides in medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…